ECHO Study Master Q&A

ECHO Study Master Q&A This Q&A covers background information, next steps, and implications following the results of the ECHO Study.       Published: 2019 Source: WHO Back to...

ECHO Study Results at SA AIDS 2019 Conference (Video)

ECHO Study Results at SA AIDS 2019 Conference The results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) study were released on June 13, 2019, 14:00-15:30 SAST, at the 9th SA AIDS Conference. The session included presentations on the primary...

MEDIA RELEASE – ECHO finds no substantial difference in HIV risk among DMPA-IM, copper IUD, and LNG implant users

MEDIA RELEASE – ECHO finds no substantial difference in HIV risk among DMPA-IM, copper IUD, and LNG implant usersWHO Statement on Depot-medroxyprogesterone acetate (DMPA) A pivotal clinical trial to address a long-standing question about the relationship between...

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial Observational and laboratory studies suggest that some hormonal...

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say By Kelli RogersDevex There is no substantial difference in HIV risk among three highly effective methods of contraception, the results of a randomized clinical trial conducted in...